首页> ACS nano> Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor.

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor.

导出 OA

翻译打印收藏纠错

第一作者： Flavia,Fontana

第一单位： Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland.

作者： Flavia,Fontana ^[1] ; Manlio,Fusciello ^[2] ; Christianne,Groeneveldt ^[3] ; Cristian,Capasso ^[2] ; Jacopo,Chiaro ^[2] ; Sara,Feola ^[2] ; Zehua,Liu ^[1] ; Ermei M,Mäkilä ^[4] ; Jarno J,Salonen ^[4] ; Jouni T,Hirvonen ^[1] ; Vincenzo,Cerullo ^[5] ; Hélder A,Santos ^[6]

作者单位： Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland. ^[1] Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland. ^[2] Division of Biotherapeutics, Leiden Academic Center for Drug Research (LACDR) , Leiden University , 2300 RA Leiden , Netherlands. ^[3] Laboratory of Industrial Physics, Department of Physics and Astronomy , University of Turku , FI-20014 Turku , Finland. ^[4] Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland.;Helsinki Institute of Life Science (HiLIFE) , University of Helsinki , FI-00014 Helsinki , Finland. ^[5] Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland.;Helsinki Institute of Life Science (HiLIFE) , University of Helsinki , FI-00014 Helsinki , Finland. ^[6]

关键词 biohybrid cancer vaccine cell membrane melanoma microfluidics